Secondary |
Drug Use For Unknown Indication |
37.2% |
Product Used For Unknown Indication |
24.8% |
Constipation |
5.3% |
Myalgia |
5.3% |
Musculoskeletal Pain |
4.4% |
Chronic Obstructive Pulmonary Disease |
3.5% |
Pain |
2.7% |
Cholecystitis |
1.8% |
Cholinergic Syndrome |
1.8% |
Depression |
1.8% |
Gastric Ulcer |
1.8% |
Prophylaxis |
1.8% |
Sleep Disorder |
1.8% |
Atrial Fibrillation |
0.9% |
Cardiac Disorder |
0.9% |
Cryoglobulinaemia |
0.9% |
Erythema |
0.9% |
Hepatitis C |
0.9% |
Herpes Ophthalmic |
0.9% |
Hyperphosphataemia |
0.9% |
|
Vomiting |
23.7% |
Pneumomediastinum |
10.5% |
Urticaria |
7.9% |
Alanine Aminotransferase Increased |
5.3% |
Hallucination |
5.3% |
Hepatitis |
5.3% |
Renal Failure Acute |
5.3% |
Suicide Attempt |
5.3% |
Arrhythmia |
2.6% |
Aspartate Aminotransferase Increased |
2.6% |
Chorea |
2.6% |
Deep Vein Thrombosis |
2.6% |
Eczema |
2.6% |
Fall |
2.6% |
Febrile Neutropenia |
2.6% |
Gastrointestinal Necrosis |
2.6% |
Gastrointestinal Sounds Abnormal |
2.6% |
Hallucination, Visual |
2.6% |
Jaundice |
2.6% |
Platelet Count Decreased |
2.6% |
|
Concomitant |
Product Used For Unknown Indication |
31.8% |
Drug Use For Unknown Indication |
14.3% |
Hypertension |
6.7% |
Constipation |
6.6% |
Pain |
6.1% |
Depression |
5.2% |
Anxiety |
4.0% |
Epilepsy |
3.5% |
Pyelonephritis |
2.4% |
Prophylaxis |
2.3% |
Multiple Myeloma |
2.1% |
Thrombosis Prophylaxis |
2.1% |
Cardiac Failure |
1.9% |
Hodgkin's Disease |
1.9% |
Prostate Cancer |
1.7% |
Essential Hypertension |
1.6% |
Neuralgia |
1.5% |
Gastric Cancer |
1.4% |
Hiv Infection |
1.4% |
Psychotic Disorder |
1.4% |
|
Vomiting |
14.7% |
Somnolence |
9.2% |
Overdose |
6.7% |
Renal Failure |
6.7% |
Renal Failure Acute |
6.1% |
Hyponatraemia |
5.5% |
Malaise |
4.9% |
Neutropenia |
4.3% |
Weight Increased |
4.3% |
Henoch-schonlein Purpura |
3.7% |
Hypotension |
3.7% |
Interstitial Lung Disease |
3.7% |
Leukopenia |
3.7% |
Thrombocytopenia |
3.7% |
Tremor |
3.7% |
Confusional State |
3.1% |
Drug Interaction |
3.1% |
Off Label Use |
3.1% |
Pancytopenia |
3.1% |
Rhabdomyolysis |
3.1% |
|